Skip to content

Clinical trials

Cholangiocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Clear all

778 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20032
20046
20053
20066
20077
200811
200913
20108
201118
201220
201320
201431
201529
201626
201740
201843
201944
202061
202155
202261
202354
202490
202556
202661

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed226
Recruiting165
Unknown status132
Terminated97
Active, not recruiting57
Not yet recruiting53
Withdrawn32
Enrolling by invitation7
Suspended3
No longer available2
Available2
Approved for marketing2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)22
Shanghai Zhongshan Hospital16
Mayo Clinic14
Fudan University13
Tianjin Medical University Cancer Institute and Hospital11
M.D. Anderson Cancer Center10
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest9
Peking Union Medical College Hospital8
Sun Yat-sen University8
Washington University School of Medicine8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma778
Pancreatic Neoplasms126
Carcinoma, Hepatocellular115
Gallbladder Neoplasms110
Biliary Tract Neoplasms99
Colorectal Neoplasms88
Liver Neoplasms75
Stomach Neoplasms74
Bile Duct Neoplasms72
Ovarian Neoplasms53

Trials

Showing 26 to 50 of 778. Each trial links to its page on Pharma Observatory.

678 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.